Tel Aviv, Israel

Orgad Laub

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Orgad Laub: Innovator in Immunoglobulin Therapeutics

Introduction

Orgad Laub is a notable inventor located in Tel Aviv, Israel, and has made significant contributions to the field of biopharmaceuticals, particularly in the development of immunoglobulin preparations. With a total of four patents to his name, his work focuses on advancing treatment options for various diseases associated with the hepatitis B virus and pathogenic microorganisms.

Latest Patents

Orgad’s most recent patents include innovations in the subcutaneous administration of anti-hepatitis B antibodies. This patent details an immunoglobulin preparation aimed at treating, preventing, and reducing diseases related to the hepatitis B virus. Additionally, he has also patented an intravenous immunoglobulin composition that provides a concentrated treatment for individuals vaccinated against or infected with harmful microorganisms, notably including smallpox and vaccinia viruses. The process outlined in this patent involves selecting populations with high antibody titers, combining their blood, and purifying the resulting immunoglobulin composition to enhance effectiveness.

Career Highlights

Orgad Laub works at Omrix Biopharmaceuticals Inc., a company known for its commitment to innovative biopharmaceutical solutions. His expertise in immunology and his inventive approach have positioned him as a key player in developing therapeutic preparations that address critical health issues.

Collaborations

Throughout his career, Orgad has collaborated with talented individuals including Israel Nur and Liliana Bar. These partnerships have undoubtedly played a significant role in enhancing the research and development processes in which he is involved, leading to successful innovations in the biopharmaceutical sector.

Conclusion

In summary, Orgad Laub's contributions to immunoglobulin therapeutics exemplify the importance of innovation in medicine. His patents not only represent significant advancements in the treatment of diseases associated with the hepatitis B virus and other pathogenic microorganisms but also highlight his role as an influential inventor in the biopharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…